Count on Actum to seamlessly complement your team, adding guidance, grit and guardrails on your way to commercial success

We add new insight to your product journey.

We begin all of our relationships with Actum’s Comprehensive Corporate Diagnosis, enabling our team to create a customized risk mitigation plan to build strength where it is needed and avoid critical missteps at every point of inflection. We stand shoulder-to-shoulder with you along the way, looking around the corner, identifying areas for course correction and building the data-driven proof points needed for product success and maximum company valuation. 

We help you plan for the unplanned.

Setting up your plan may seem like the hard part, but in reality, success is often determined by how well your team responds to the unplanned. Do you have the right funding strategy to make it to launch? Do you have the resources and expertise to address the unforeseen? What adaptations should you make to address roadblocks to your plan? The answers to these questions are not absolute, but a series of interrelated tradeoffs.  Our team brings the collective wisdom of multiple product launches, from small molecule to cell & gene therapies, to help reinforce your plan.

We have experience in a range of therapeutic categories.

With a patient-centric view, we understand building a viable biopharma business is not a one-size-fits-all proposition. We appreciate the differences, both big and nuanced, in the business building approach needed for different therapeutic categories. Our team has a range of experience that includes both small molecule and cell & gene therapies, with a special focus on rare disease strategy and execution.